The proof suggests nearly all enterprise leaders are piloting or investing in AI initiatives, and biopharmaceutical big Boehringer Ingelheim is dedicated to investing in rising expertise that would have life-altering penalties.The corporate's 55,000 staff give attention to creating modern...